Stock Price Quote

ORTIN GLOBAL LTD.

NSE : ORTINGLOBEBSE : 539287ISIN CODE : INE749B01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE12.160.57 (+4.92 %)
PREV CLOSE ( ) 11.59
OPEN PRICE ( ) 12.16
BID PRICE (QTY) 12.16 (203)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 748
TODAY'S LOW / HIGH ( )12.16 12.16
52 WK LOW / HIGH ( )9.57 22.88
NSE12.410.59 (+4.99 %)
PREV CLOSE( ) 11.82
OPEN PRICE ( ) 12.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23248
TODAY'S LOW / HIGH( ) 11.70 12.41
52 WK LOW / HIGH ( )9.64 20.88
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-10 1986
Management Info
- Chairman S Murali Krishna Murthy - Managing Director
Registered Office

Address D. No: 1-8-305, Ground Floor,Chikkadpally, ,
Hyderabad,
Telangana-500020

Phone 040-27567266 / 27562055

Email info@ortinlabsindia.com

Website www.ortinlabsindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

19May Ortin Global submits board meeting int
Ortin Global has informed that pursuant to the provisions of Regulation-..
01Apr Ortin Global informs about outcome of
Ortin Global has informed that the Board of Directors of the company (Fo..
27Dec Ortin Global informs about closure of
Pursuant to the Company’s Code of Conduct for Prevention of Insider Trad..
22May Ortin Laboratories informs about board
Pursuant to Regulation 29 read with Regulation 33 of the Securities and..
02Apr Ortin Laboratories informs about discl
Ortin Laboratories has informed that the exchange has received the discl..

Financials

in Millions
QTR Jun 25 ANNUAL 25
Net Profit-1.74-8.46
Gross Profit -1.62 -8.37
Operating Profit -1.62-8.41
Net Sales 0.813.83

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  17550.00 (2.03%)
M.Cap ( in Cr)22389.38
Alkem Laboratories (BSE)
peergroup  5787.70 (1.52%)
M.Cap ( in Cr)68496.40
Astrazeneca Pharma I (BSE)
peergroup  9212.95 (0.89%)
M.Cap ( in Cr)23146.13
Lupin (BSE)
peergroup  2035.85 (3.04%)
M.Cap ( in Cr)91809.20
Mankind Pharma (BSE)
peergroup  2280.20 (2.70%)
M.Cap ( in Cr)92870.66

Shareholding Pattern

NON-INSTITUTION 97.09%
PROMOTERS 1.23%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Ortin Global Ltd.

Ortin Global Ltd. was incorporated in the year 1986. Its today's share price is 12.16. Its current market capitalisation stands at Rs 9.89 Cr. In the latest quarter, company has reported Gross Sales of Rs. 21.12 Cr and Total Income of Rs.22.85 Cr. The company's management includes Mounika Pammi, Ajay Vishwakarma, Madhu Mala Solanki, S Balaji Venkateswarlu, Pramod Dnyandeo Waghe, S Srinivas Kumar, S Murali Krishna Murthy.

It is listed on the BSE with a BSE Code of 539287 , NSE with an NSE Symbol of ORTINGLOBE and ISIN of INE749B01020. It's Registered office is at D. No: 1-8-305, Ground Floor,Chikkadpally, Hyderabad-500020, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Mathesh & Ramana, Sathuluri & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.